ABSTRACT
INTRODUCTION
Sclerosing mesenteritis is an uncommon inflammatory disease of the intestinal mesenteric fat tissue. [1] [2] [3] [4] The etiology remains unknown and hypothesized to be associated with previous abdominal surgery, abdominal trauma, autoimmune disease, drugs, cancer, ischemia, and infection. [5] [6] [7] The prevalence is 0.16-7.8%. Sclerosing mesenteritis is also reported in 0.6% of over than 7,000 patients undergoing abdominal computed tomography (CT) scan for other indications. 8 Clinical manifestations of sclerosing mesenteritis (SM) are not specific, varying from asymptomatic to abdominal pain, bloating, nausea, vomiting, weight loss, constipation, diarrhea, and fever. 9, 10 Diagnosis is not always conclusive on clinical findings and radiological examinations only. Definitive diagnosis is confirmed by histopathological evaluation.
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In approximately 69% of patients with SM, there are some concurrent malignancies such as lymphoma, urogenital cancer, and gastrointestinal cancer. 12 In case series by Vlachos, et al 12 , 2 of 5 patients had colon malignancies (caecal and sigmoid colon cancer). Contrary to those reports, other literatures describe that the prevalence of cancer in SM patients is not different with the general population. The hypothesis that supports SM as a paraneoplastic syndrome is still controversial. 7 This is a case of a male patient with the diagnosis of SM and poorly-differentiated caecal adenocarcinoma. The importance of SM diagnostic findings and relationship of SM with caecal adenocarcinoma will be highlighted. As far as we know, it is the first reported case in Indonesia.
CASE ILLUSTRATION
A 45-year-old male was referred to our hospital with a chief complaint of continuous vomiting since 11 days before admission. He had been complaining of nausea, vomiting, early satiety, and vague abdominal discomfort for the last six months. He was given antacids and ranitidine with no improvement. Four months ago he underwent an abdominal CT scan, and the result showed intestinal and peritoneal TB. He refused colonoscopy at the time. Laparoscopic biopsy result was suggestive of peritoneal TB. He was given anti-TB drugs started four months before admission. He consumed anti-TB drugs for only two months without any improvements.
Since two months before admission, he had been vomiting more frequently. He also had non-bloody diarrhea alternating with constipation. He had had progressive symptoms and signs of intestinal obstruction and underwent laparotomy at another hospital. After one month of hospitalization, he was discharged. Eleven days before admission, he was rehospitalized due to worsening continuous vomiting and obstipation. He had involuntary weight loss as much as 30 kg within the last four months.
Physical examination upon admission showed that he was fully alert with a body mass index of 14.7 kg/m 2 . Nasogastric tube (NGT) was inserted, producing greenish-colored fluid followed by coffeeground appearance fluid. Abdominal examination revealed doughnut-like consistency, dull to percussion, decreased abdominal skin turgor and decreased bowel sounds. Other physical examinations were within normal limits.
Laboratory examination upon admission showed leucocytosis, and decreased albumin levels. Carcinoembryonic antigen (CEA) was 10.55 ng/mL (normal value 0-4.6 ng/mL). Previous abdominal CT scan performed in another hospital showed fluid collection surrounding the liver, spleen, bilateral paracolic, intestinal, pelvic cavity, with mild enhancement in peripheral area. It also showed adhesion and inflammation of the small bowel beginning from duodenojejunal junction until distal ileum, transverse colon, and rectosigmoid colon, causing luminal narrowing and dilatation of duodenum and gaster. Previous abdominal paracentesis showed inconclusive results.
Patient was admitted to our hospital and underwent several examinations. Anterograde double balloon enteroscopy (DBE) revealed erosive gastropathy with gastric mucosal edema and multiple adhesions at the jejunum. Nasojejunal feeding tube (NJFT) and NGT were inserted for nutritional access and decompression, respectively. His repeated abdominal CT scan on the sixth day of current hospitalization showed ascites, thickening of bowel wall and peritoneum without any signs of ileus. The initial results of omentum biopsy from another hospital showed non-specific granulomatous inflammation without any signs of malignancy.
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However the specimen was reevaluated in our hospital and showed SM with no signs of malignancy.
DISCUSSION
Clinical manifestations of SM are not specific. Based on study by Plasencia et al abdominal discomfort was reported in two patients, weight loss in four patients, nausea in five patients, vomiting in six patients, abdominal pain in five patients. Another study by Akram et al showed that 10% were asymptomatic, 70% had abdominal pain, 26% had bloating, 25% had diarrhea, 23% had weight loss, 21% had nausea and vomiting, 16% had loss of appetite, 15% had constipation, 6% had fever, and 3% had night sweats. 5, 13 On physical examination, the study showed normal abdominal examination in 51% patients, abdominal tenderness in 24% patients, abdominal mass in 15% patients, and chylous ascites in 14% patients. 13 This patient had nausea, vomiting, early satiety, and vague abdominal discomfort. Later on, he also complained of diarrhea, constipation, weight loss, and signs of abdominal tenderness and intestinal obstruction. He had no fever and night sweats. Generally, the clinical findings of this patient were in concordance with those described in the studies.
The CT scan findings of SM showed increased mesenterium attenuation to a solid soft tissue mass. Preservation of fat around the mesenteric vessels which is recognized as "fat ring sign" and also calcification may be discovered. Significant mesenteric vessels involvement could disturb the bowel blood vessel flow and cause bowel wall thickening due to ischemia and ascites. 14 The patient's abdominal CT scan showed no fat ring sign nor calcification. However, there were thickening of the small bowel wall and peritoneum. Ascites was also identified. Some of the patient's abdominal CT scan findings were in concordance with the literatures.
Definitive diagnosis of SM requires biopsy and histopathological evaluation. Sclerosing mesenteritis has been described in three phases. The first phase is fat necrosis or mesenteric lipodystrophy. It is followed by the second phase, mesenteric panniculitis which is related to inflammatory process. The third phase is retractile mesenteritis which is marked by fibrosis with mesenteric retraction and shortening. 15 Evaluation of the biopsy specimen from the omentum in our hospital revealed fibrotic tissue, adipose tissue, inflammatory cells, congestive vessels without specific infection or malignancy. It was consistent with SM in the third phase.
After the thorough explanations regarding the diagnostic findings in the above paragraphs, another issue of SM emerges. As illustrated in the case, our Colonoscopy was also performed to evaluate the possibility of cancer. The procedure revealed that the entire colon was edematous and hyperemic and the hematoxyllin-eosin (HE) staining of the specimen taken from caecum showed poorly-differentiated caecal adenocarcinoma. He was given partial parenteral nutrition, intravenous fluid, liquid diet via NJFT, and methyl prednisolone 62.5 mg twice daily intravenously, which was tapered down to 16 mg daily for three weeks. The response was inadequate and it was decided to do a laparotomy. The result was frozen abdomen and the surgery was halted. Afterwards, he suffered septic shock due to hospital acquired pneumonia and passed away. patient suffered from both SM and poorly differentiated caecal adenocarcinoma. Question arises whether it was a cause-effect relationship or just a coincidence.
Some studies were designed to answer the question. A research conducted by Gogebakan et al. 1 showed an interesting fact. They studied 56 patients with SM and malignancies compared to 150 patients with malignancies and no SM (the control group). From those subjects, there were 12 (15.6%) colorectal cancer (CRC) patients in SM group and 26 (17.1%) CRC patients in control group. The analysis showed non-significant differences of CRC prevalence between those two groups (p = 0.852). 1 The limitations of the study were the small number of SM and CRC cases and also the reliance of the SM diagnosis on radiological examination only and not by histopathology as the gold standard. Another study by van Putte-Katier et al. 6 contradicts the previous research. They studied 46 SM patients with cancer and 87 malignancies patients without SM (the control group). There were 8 (17.4%) CRC patients in SM group and 18 (20.7%) CRC patients in control group. The prevalence of CRC was significantly lower in SM group compared to control group. The limitation of their study was the absence of histopathological proof of SM. 6 Both studies did not specifically describe the location of the CRC (whether it is caecal cancer or not). As for know, the relationship between SM and caecal adenocarcinoma remains unclear. Further studies are needed to clarify this issue.
In conclusion, sclerosing mesenteritis is a rare mesenteric inflammatory disorder, which still has vague correlations with cancer, particularly caecal adenocarcinoma. Clinical findings of SM are not specific and the diagnosis should be supported by radiological investigation, and confirmed by histopathological examination.
